TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28340091

Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanate
Number of subjects: 319

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Recurrence of AOM during follow-up
Number of subjects: 319

Group type: COMPARATOR
Intervention: No recurrence of AOM during follow-up
Number of subjects: 319
Study: 27133392

Group type: EXPERIMENTAL
Intervention: Narrative vignettes in newsletters
Number of subjects: 21526

Group type: COMPARATOR
Intervention: Control newsletters with descriptive text
Number of subjects: 21526
Study: 27018027

Group type: EXPERIMENTAL
Intervention: Group B (Ibuprofen + amoxicillin, clavulanic acid)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Group A (Ibuprofen only)
Number of subjects: 129
Study: 23703896

Group type: EXPERIMENTAL
Intervention: Enoxaparin (4000 IU/day, subcutaneously for 48 weeks)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 70
Study: 20575711

Group type: EXPERIMENTAL
Intervention: Hormone therapy suspension for 1 or 2 months before the next screening mammogram.
Number of subjects: 881
Study: 19106467

Group type: EXPERIMENTAL
Intervention: Group 1: sandblasting with 50‐microm aluminum oxide and 37% phosphoric acid etching (PA)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Group 2: bur roughening and etching with 37% PA
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Group 3: etching with 37% PA only
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Gradia Direct (GD)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Gradia (G)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Gradia Forte (GF)
Number of subjects: 3
Study: 16870057

Group type: EXPERIMENTAL
Intervention: Actor prototypes
Number of subjects: 247

Group type: COMPARATOR
Intervention: Abstainer prototypes
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: PWM variables
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Perceived similarity to prototypes
Number of subjects: 247
Study: 14960214

Group type: EXPERIMENTAL
Intervention: Multifaceted training programme (the TERM model)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 43
Study: 11094363

Group type: EXPERIMENTAL
Intervention: Clark Twin‐block appliance for 6 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 40
Study: 8637789

Group type: EXPERIMENTAL
Intervention: Biweekly schedule of 1.2 million U intramuscular benzathine penicillin G (BPG)
Number of subjects: 360

Group type: COMPARATOR
Intervention: 4-week schedule of 1.2 million U intramuscular benzathine penicillin G (BPG)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Locally manufactured BPG brand (4-week schedule)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Imported BPG brand (4-week schedule)
Number of subjects: 360
Study: 1519396

Group type: EXPERIMENTAL
Intervention: Ender-nails
Number of subjects: 100

Group type: COMPARATOR
Intervention: Dynamic hip screws
Number of subjects: 100
Study: 3886600

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Mianserine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 31125274

Group type: EXPERIMENTAL
Intervention: Brigatinib treatment
Number of subjects: 208
Study: 28371789

Group type: EXPERIMENTAL
Intervention: Novel classification approach based on nonlinear model identification framework
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Distance correlation filtering as a preprocessing technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison with other well-known FS and classification methods
Number of subjects: 0
Study: 26892777

Group type: EXPERIMENTAL
Intervention: Atazanavir plus didanosine-EC plus emtricitabine
Number of subjects: 84
Study: 25193555

Group type: EXPERIMENTAL
Intervention: Two weeks of immobilization followed by six weeks of supervised cycle training
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Two weeks of immobilization
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Six weeks of supervised cycle training
Number of subjects: 32

Group type: COMPARATOR
Intervention: Young men
Number of subjects: 32

Group type: COMPARATOR
Intervention: Elderly men
Number of subjects: 32
Study: 22418005

Group type: EXPERIMENTAL
Intervention: Temporary sacral nerve stimulation (SNS)
Number of subjects: 14
Study: 19997004

Group type: EXPERIMENTAL
Intervention: VMO motor control retraining (MCR)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Quadriceps strengthening (QS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both MCR and QS
Number of subjects: 60
Study: 17666608

Group type: EXPERIMENTAL
Intervention: Group prenatal care
Number of subjects: 1047

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1047
Study: 16272960

Group type: EXPERIMENTAL
Intervention: GW320659 (15 mg/day)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 191
Study: 11862132

Group type: EXPERIMENTAL
Intervention: Cola drink
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Chocolate milk (CM)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Orange juice (OJ)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Water
Number of subjects: 30
Study: 10197321

Group type: EXPERIMENTAL
Intervention: Coumarin 90 mg/day (Group A)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Coumarin 135 mg/day (Group B)
Number of subjects: 77
Study: 8657434

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 60 mg/ml
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Indomethacin 4.5 mg/ml
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Salicylic acid (SA) 60 mg/ml
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) and Salicylic acid (SA) with higher flow rate of acid buffer
Number of subjects: 30
Study: 2182235

Group type: EXPERIMENTAL
Intervention: Intravenous anistreplase (Eminase)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Intracoronary streptokinase
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Intravenous anistreplase (Eminase) and Intracoronary streptokinase
Number of subjects: 240
Study: 114042

Group type: EXPERIMENTAL
Intervention: Low-lactose milk (500 ml twice daily for 1 month)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Unmodified milk (same volume as low-lactose milk during double-blind tests)
Number of subjects: 31
Study: 31147363

Group type: EXPERIMENTAL
Intervention: Yoga intervention (12-week program)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Aerobic exercise (comparison group)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Non-active wait-list control (comparison group)
Number of subjects: 180
Study: 28925468

Group type: EXPERIMENTAL
Intervention: Carboplatin plus Paclitaxel plus Bevacizumab (CPB)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Carboplatin plus Paclitaxel (CP)
Number of subjects: 102
Study: 25556539

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.75%, 20 mL
Number of subjects: 46

Group type: COMPARATOR
Intervention: 0.9% saline, 20 mL
Number of subjects: 46
Study: 24144222

Group type: EXPERIMENTAL
Intervention: Nebulised magnesium sulphate (MgSO4) 151 mg
Number of subjects: 508

Group type: COMPARATOR
Intervention: Standard treatment (placebo)
Number of subjects: 508
Study: 20350170

Group type: EXPERIMENTAL
Intervention: Electroencephalographic activities recorded during speech production monitoring experiments.
Number of subjects: 0
Study: 19189997

Group type: EXPERIMENTAL
Intervention: Apligraf
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 72
Study: 16752282

Group type: EXPERIMENTAL
Intervention: Porous‐coated press‐fit cup with ceramic coating (Trilogy, uncemented)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Acrylic cement with gentamicin (Palacos)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Acrylic bone cement with fluoride (Cemex‐F)
Number of subjects: 90
Study: 15129701

Group type: EXPERIMENTAL
Intervention: FDG PET
Number of subjects: 55

Group type: COMPARATOR
Intervention: SLL
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Negative FDG PET
Number of subjects: 55

Group type: COMPARATOR
Intervention: Negative SLL
Number of subjects: 55
Study: 11435682

Group type: EXPERIMENTAL
Intervention: Lying on the left side
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Sitting in a chair
Number of subjects: 129
Study: 9052578

Group type: COMPARATOR
Intervention: Educational information about osteoporosis and a voucher for a bone mineral density test 12 months later
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Educational information plus an immediate dual‐energy x‐ray absorptiometry test for bone mineral density
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Bone mineral density test results (osteopenic or osteoporotic)
Number of subjects: 140
Study: 8359600

Group type: EXPERIMENTAL
Intervention: Reflotron (desk-top analyser)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no desk-top analyser)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 3459390

Group type: EXPERIMENTAL
Intervention: Imipenem coadministered with cilastatin (1 g of imipenem and equal amounts of cilastatin)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Moxalactam (2 g)
Number of subjects: 6
Study: 31934593

Group type: EXPERIMENTAL
Intervention: Community-nurse-led multidisciplinary team management for 2 years
Number of subjects: 179

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 179
Study: 30003514

Group type: EXPERIMENTAL
Intervention: Paediatric rotary files Kedo-S
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hand K-files (Control)
Number of subjects: 60
Study: 26244417

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) as an adjunct to Light Therapy (LT) for four weeks after two weeks of LT.
Number of subjects: 0

Group type: COMPARATOR
Intervention: No Treatment (NT) after two weeks of Light Therapy (LT).
Number of subjects: 0
Study: 24560179

Group type: EXPERIMENTAL
Intervention: Umbilical cord milking (UCM)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Immediate cord clamping (ICC)
Number of subjects: 60
Study: 22525670

Group type: EXPERIMENTAL
Intervention: Noninvasive cortical stimulation therapy
Number of subjects: 69
Study: 20036404

Group type: EXPERIMENTAL
Intervention: Exercise at simulated altitude of 2000 m
Number of subjects: 7

Group type: COMPARATOR
Intervention: Exercise at sea level
Number of subjects: 7
Study: 18759343

Group type: EXPERIMENTAL
Intervention: Subthalamic nucleus high-frequency stimulation (STN-HFS)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 10
Study: 16227664

Group type: EXPERIMENTAL
Intervention: RCTs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other types of evidence
Number of subjects: 0
Study: 12625990

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 10079411

Group type: EXPERIMENTAL
Intervention: St. John's wort (0.6 mg/mL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Saw-palmetto (high concentration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Echinacea purpura (high concentration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba (high concentration)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control medium
Number of subjects: 0
Study: 7588925

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 2184134

Group type: EXPERIMENTAL
Intervention: Thymopentin (TP-5) at 50 mg s.c. three times per week for one month
Number of subjects: 13

Group type: COMPARATOR
Intervention: Thymopentin (TP-5)
Number of subjects: 13
Study: 7017019

Group type: EXPERIMENTAL
Intervention: Selective antimicrobial modulation (SAM)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study: 30955912

Group type: EXPERIMENTAL
Intervention: HADS-A score ≥ 8
Number of subjects: 88
Study: 28295825

Group type: EXPERIMENTAL
Intervention: Manual therapy (n=50), three sessions (once/week) including desensitization manoeuvres of the central nervous system
Number of subjects: 100

Group type: COMPARATOR
Intervention: Surgery (n=50)
Number of subjects: 100
Study: 26141263

Group type: EXPERIMENTAL
Intervention: Nasal filters (Rhinix; Rhinix ApS, Aarhus, Denmark)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 23632170

Group type: EXPERIMENTAL
Intervention: Tongue Drive System (TDS)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: tongue-protrusion task (TPT)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: therapeutic tongue exercises (TTE)
Number of subjects: 48

Group type: COMPARATOR
Intervention: first dorsal interosseous (FDI) (control)
Number of subjects: 48
Study: 21321461

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg/d
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 19762749

Group type: EXPERIMENTAL
Intervention: Advanced cardiac life support
Number of subjects: 1166

Group type: EXPERIMENTAL
Intervention: Ventricular fibrillation
Number of subjects: 1166

Group type: EXPERIMENTAL
Intervention: Asystole
Number of subjects: 1166

Group type: EXPERIMENTAL
Intervention: Logistic regression model
Number of subjects: 1166
Study: 17257478

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 23983
Study: 15533491

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (n = 34)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (n = 36)
Number of subjects: 70
Study: 11508581

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) in combination with low dose corticosteroids after 12 months of therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20
Study: 9635948

Group type: EXPERIMENTAL
Intervention: Cerebral MRI findings
Number of subjects: 80
Study: 7826827

Group type: EXPERIMENTAL
Intervention: Bendrofluazide (10 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Oxazepam (15 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Bendrofluazide
Number of subjects: 12

Group type: COMPARATOR
Intervention: Oxazepam
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Bendrofluazide and Oxazepam
Number of subjects: 12
Study: 2825820

Group type: EXPERIMENTAL
Intervention: Ethanol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ethanol placebo
Number of subjects: 0
Study: 29308927

Group type: EXPERIMENTAL
Intervention: High dose CRMRF
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Low dose CRMRF
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo CRMRF
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: High dose PSWT
Number of subjects: 17
Study: 26697548

Group type: EXPERIMENTAL
Intervention: Test group (TG) - impingement of periodontal biologic width with transsurgical restorations
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (CG) - supragingival restorations after crown lengthening
Number of subjects: 10
Study: 24767220

Group type: EXPERIMENTAL
Intervention: Parkinson's disease patients (H-Y 1-2)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Parkinson's disease patients (H-Y 3-5)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 55
Study: 22149129

Group type: EXPERIMENTAL
Intervention: Listening to an interview with fellow cancer survivors (content about negative emotions and effective coping strategies)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Control condition (not specified)
Number of subjects: 139
Study: 20028728

Group type: EXPERIMENTAL
Intervention: NSAIDs/Coxibs (celecoxib, naproxen/ketoprofen)
Number of subjects: 851

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 851
Study: 18578176

Group type: EXPERIMENTAL
Intervention: Renew direct resin composite
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Renew direct resin composite inlay
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Tescera indirect resin composite inlay
Number of subjects: 50

Group type: COMPARATOR
Intervention: non-restored
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: intact
Number of subjects: 50
Study: 15706464

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 74

Group type: COMPARATOR
Intervention: Nortriptyline
Number of subjects: 74
Study: 12627998

Group type: EXPERIMENTAL
Intervention: Pyridostigmine (45 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 10596458

Group type: EXPERIMENTAL
Intervention: Usual dose of insulin (0.1 U/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low dose of insulin (0.05 U/kg)
Number of subjects: 12
Study: 8763654

Group type: EXPERIMENTAL
Intervention: Surgery and radiotherapy
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Post-operative Karnofski Performance Status
Number of subjects: 32
Study: 1913493

Group type: EXPERIMENTAL
Intervention: DDP with DSM (600 mg degradable starch microspheres)
Number of subjects: 8

Group type: COMPARATOR
Intervention: DDP alone (25 mg/m2)
Number of subjects: 8
Study: 7250094

Group type: EXPERIMENTAL
Intervention: 4 miles on alternate days for 1 month
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 8 miles on alternate days for 1 month
Number of subjects: 15

Group type: COMPARATOR
Intervention: 0 miles on alternate days for 1 month
Number of subjects: 15
Study: 31222044

Group type: EXPERIMENTAL
Intervention: Ferric citrate hydrate (FC)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control (non-iron-based phosphate binders)
Number of subjects: 93
Study: 31313548

Group type: EXPERIMENTAL
Intervention: Triple pill of telmisartan/amlodipine/hydrochlorothiazide
Number of subjects: 512

Group type: COMPARATOR
Intervention: Dual combination of telmisartan/hydrochlorothiazide
Number of subjects: 512
Study: 26794729

Group type: EXPERIMENTAL
Intervention: Docetaxel with Strontium-89 (Sr89)
Number of subjects: 757

Group type: EXPERIMENTAL
Intervention: Docetaxel with Zoledronic Acid (ZA)
Number of subjects: 757

Group type: COMPARATOR
Intervention: Docetaxel alone
Number of subjects: 757

Group type: EXPERIMENTAL
Intervention: Docetaxel with both ZA and Sr89
Number of subjects: 757
Study: 24129543

Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral therapy (Coping Cat)
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Medication (sertraline)
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Combination of cognitive‐behavioral therapy and medication
Number of subjects: 488

Group type: COMPARATOR
Intervention: Pill placebo
Number of subjects: 488
Study: 22282500

Group type: EXPERIMENTAL
Intervention: IL6 donor genotype for rs1800795
Number of subjects: 1298

Group type: EXPERIMENTAL
Intervention: IL10 associations
Number of subjects: 1298

Group type: EXPERIMENTAL
Intervention: Other SNPs (IL2, CTLA4, HPSE, MTHFR)
Number of subjects: 1298
Study: 20101920

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) intervention
Number of subjects: 424

Group type: COMPARATOR
Intervention: Comparison intervention (educational meetings)
Number of subjects: 424
Study: 17324657

Group type: EXPERIMENTAL
Intervention: Nutrition intervention (nutrition counseling following the ADA medical nutrition therapy protocol)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nutrition intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard practice
Number of subjects: 60
Study: 15014864

Group type: EXPERIMENTAL
Intervention: Hypromellose and Lacri‐Lube combination (HL)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Polyethylene covers
Number of subjects: 110
Study: 11772822

Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 45

Group type: COMPARATOR
Intervention: Nitroglycerin
Number of subjects: 45

Group type: COMPARATOR
Intervention: Prostaglandin E(1)
Number of subjects: 45
Study: 9659017

Group type: EXPERIMENTAL
Intervention: midazolam 0.08 mg.kg‐1
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: morphine 0.15 mg.kg‐1
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: clonidine 2 micrograms.kg‐1
Number of subjects: 95

Group type: COMPARATOR
Intervention: normal saline
Number of subjects: 95
Study: 8595681

Group type: EXPERIMENTAL
Intervention: Lidocaine hydrochloride 2% (HCl)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Alkalinized lidocaine 2% (1 ml NaHCO3 per 10 ml of solution) injected immediately
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Alkalinized lidocaine 2% (1 ml NaHCO3 per 10 ml of solution) injected one hour after preparation
Number of subjects: 45
Study: 2668006

Group type: EXPERIMENTAL
Intervention: Intravenous L-carnitine at a dose of 100 mg kg‐1 b.w. every 12 h for 36 h
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo intravenously
Number of subjects: 56
Study: 304442

Group type: EXPERIMENTAL
Intervention: 5 TU Battey test
Number of subjects: 2168

Group type: EXPERIMENTAL
Intervention: 20 TU RT 23 test
Number of subjects: 2168
Study: 31187437

Group type: EXPERIMENTAL
Intervention: 300-mg single-dose tafenoquine
Number of subjects: 467

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 467
Study: 28437278

Group type: EXPERIMENTAL
Intervention: Landiolol (12 mg/mL formulation) administered via dose-escalation regimen (10 μg/kg BW/min for 2 hours, 20 μg/kg BW/min for 2 hours, 40 μg/kg BW/min for 20 hours, 6 hours follow-up)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Landiolol (12 mg/mL formulation)
Number of subjects: 12
Study: 25641687

Group type: EXPERIMENTAL
Intervention: Interaction with nurses
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Touch (stress balls)
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Patient selected DVD
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Patient selected music
Number of subjects: 398

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 398
Study: 23072658

Group type: EXPERIMENTAL
Intervention: Qigong exercise program (12 weeks)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Newspaper reading program (12 weeks)
Number of subjects: 38
Study: 21576095

Group type: EXPERIMENTAL
Intervention: Combined infraclavicular block plus distal median, radial, and ulnar nerve blockade
Number of subjects: 61

Group type: COMPARATOR
Intervention: Infraclavicular block alone
Number of subjects: 61
Study: 19695549

Group type: EXPERIMENTAL
Intervention: VCD
Number of subjects: 401

Group type: COMPARATOR
Intervention: MC
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 401